Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tim Behrens is among the laureates and finalists of the 2018 Blavatnik Awards for Young Scientists in the United Kingdom, announced today by the Blavatnik Family Foundation and the New York Academy of Sciences.

Image courtesy of Nick Irving

One laureate in each of the three Blavatnik Awards categories—Life Sciences, Physical Sciences & Engineering, and Chemistry—will each receive a prize of US$100,000, and two finalists in each category will each receive US$30,000. The Blavatnik Awards in the UK are the largest unrestricted cash prizes available exclusively to young scientists in the UK.

Professor Timothy Behrens of the Nuffield Department of Clinical Neurosciences has been named as a Life Sciences Finalist. Professor Behrens investigates the biology of the brain that underlies human behaviour. By combining mathematical models with behavioural experiments and neural recordings, he has uncovered at a cellular level how the brain stores abstract information about relationships between things in the world, and how we use this mental map in decision-making. His discoveries have applications in neural network computing and artificial intelligence, but also on our understanding of cognition and mental health.

Read more on the University website

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.